Collagenase, Type 4 Reference: 252-10120 Prepared to contain lower tryptic activity levels to limit damage to membrane proteins and receptors but with normal to above normal collagenase activity. Suggested for pancreatic islet primary isolation. A dialyzed, lyophilized powder.
JGB1741 Reference: 10641-1 A SIRT1-specific inhibitor (IC50 = 15 μM); inhibits metastatic breast cancer MDA-MB 231 cell proliferation (IC50 = 512 nM), dose-dependently increasing p53 acetylation and p53-mediated apoptosis in these cells
Collagenase, Type 4, Filtered Reference: 252-10121 Collagenase, Type 4, which is filtered through a 0.22 micron membrane and lyophilized in vials.
JGB1741 Reference: 10641-10 A SIRT1-specific inhibitor (IC50 = 15 μM); inhibits metastatic breast cancer MDA-MB 231 cell proliferation (IC50 = 512 nM), dose-dependently increasing p53 acetylation and p53-mediated apoptosis in these cells
Collagenase, Type 5 Reference: 252-10122 Prepared to contain higher collagenase and caseinase activities. A dialyzed, lyophilized powder.
JGB1741 Reference: 10641-25 A SIRT1-specific inhibitor (IC50 = 15 μM); inhibits metastatic breast cancer MDA-MB 231 cell proliferation (IC50 = 512 nM), dose-dependently increasing p53 acetylation and p53-mediated apoptosis in these cells